↓ Skip to main content

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

Overview of attention for article published in Critical Care, January 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
8 X users

Readers on

mendeley
203 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
Published in
Critical Care, January 2014
DOI 10.1186/cc13183
Pubmed ID
Authors

Serge Masson, Pietro Caironi, Eberhard Spanuth, Ralf Thomae, Mauro Panigada, Gabriela Sangiorgi, Roberto Fumagalli, Tommaso Mauri, Stefano Isgrò, Caterina Fanizza, Marilena Romero, Gianni Tognoni, Roberto Latini, Luciano Gattinoni

Abstract

Sepsis, a leading cause of death in critically ill patients, is the result of complex interactions between the infecting microorganisms and the host responses that influence clinical outcomes. We evaluated the prognostic value of presepsin (sCD14-ST), a novel biomarker of bacterial infection, and compared it with procalcitonin (PCT).

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Brazil 1 <1%
Egypt 1 <1%
Spain 1 <1%
Japan 1 <1%
Unknown 198 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 14%
Student > Master 27 13%
Student > Ph. D. Student 25 12%
Student > Bachelor 16 8%
Student > Doctoral Student 14 7%
Other 54 27%
Unknown 38 19%
Readers by discipline Count As %
Medicine and Dentistry 104 51%
Biochemistry, Genetics and Molecular Biology 16 8%
Nursing and Health Professions 7 3%
Agricultural and Biological Sciences 7 3%
Immunology and Microbiology 7 3%
Other 17 8%
Unknown 45 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2016.
All research outputs
#7,356,550
of 25,374,917 outputs
Outputs from Critical Care
#4,042
of 6,554 outputs
Outputs of similar age
#79,994
of 318,514 outputs
Outputs of similar age from Critical Care
#41
of 90 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,514 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.